Cytoprotective actions of hydrogen sulfide in ischaemia-reperfusion injury

Experimental Physiology

Volumn 96, Issue 9, 2011, Pages 840-846

  King, Adrienne L ^a   Lefer, David J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE; HOMOCYSTEINE; HYDROGEN SULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEAR RESPIRATORY FACTOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN KINASE C; SERINE; SODIUM SULFIDE; STAT3 PROTEIN;

APOPTOSIS; BREATHING RATE; CELL PROTECTION; CORE TEMPERATURE; CORONARY ARTERY BLOOD FLOW; DESULFURIZATION; DRUG METABOLISM; DRUG SYNTHESIS; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PROTECTION; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE FUNCTION; INTRACELLULAR SIGNALING; ISCHEMIA; LIVER ISCHEMIA; LIVER PROTECTION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; NOTE; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

EID: 80051940012     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.059725     Document Type: Note

References (41)

1. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S & Sung B (2009). Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171, 59-76.
2. Baker RG, Hayden MS & Ghosh S (2011). NF-κB, inflammation, and metabolic disease. Cell Metab 13, 11-22.
3. Beard RS Jr & Bearden SE (2011). Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol 300, H13-H26.
4. Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, Darley-Usmar VM, Doeller JE & Kraus DW (2007). Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A 104, 17977-17982.
5. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S & Moore PK (2006). Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316, 670-678.
6. 2S induces a suspended animation-like state in mice. Science 308, 518.
7. Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, Elrod JW, Ramachandran A & Lefer DJ (2010). Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 122, 11-19.
8. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG & Lefer DJ (2009). Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105, 365-374.
9. Chen Y, Liu Z & Xie X (2010). Hydrogen sulphide attenuates renal and cardiac injury after total hepatic ischemia and reperfusion. J Surg Res 164, e305-e313.
10. Cheng Y, Ndisang JF, Tang G, Cao K & Wang R (2004). Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287, H2316-H2323.
11. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabó C, Kimura H, Chow CW & Lefer DJ (2007). Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A 104, 15560-15565.
12. Gadalla MM & Snyder SH (2010). Hydrogen sulfide as a gasotransmitter. J Neurochem 113, 14-26.
13. Halestrap AP (2006). Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 34, 232-237.
14. Halestrap AP (2010). A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans 38, 841-860.
15. Hosoki R, Matsuki N & Kimura H (1997). The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 237, 527-531.
16. Hu Y, Chen X, Pan TT, Neo KL, Lee SW, Khin ES, Moore PK & Bian JS (2008). Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch 455, 607-616.
17. Jha S, Calvert JW, Duranski MR, Ramachandran A & Lefer DJ (2008). Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol 295, H801-H806.
18. Kang K, Zhao M, Jiang H, Tan G, Pan S & Sun X (2009). Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats. Liver Transpl 15, 1306-1314.
19. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M & Moore PK (2005). Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 19, 1196-1198.
20. Li L, Rose P & Moore PK (2011). Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 51, 169-187.
21. Li L, Rossoni G, Sparatore A, Lee LC, Del Soldato P & Moore PK (2007). Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med 42, 706-719.
22. Li L, Salto-Tellez M, Tan CH, Whiteman M & Moore PK (2009). GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic Biol Med 47, 103-113.
23. 2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res 89, 891-898.
24. 2S signals through protein S-sulfhydration. Sci Signal 2, ra72.
25. Nicholson CK & Calvert JW (2010). Hydrogen sulfide and ischemia-reperfusion injury. Pharmacol Res 62, 289-297.
26. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ & Chung HT (2006). Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 41, 106-119.
27. ATP channels learned from Kir6.2 genetically engineered mice. Diabetes 49, 311-318.
28. + channels. Prog Biophys Mol Biol 81, 133-176.
29. Shanmuganathan S, Hausenloy DJ, Duchen MR & Yellon DM (2005). Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 289, H237-H242.
30. 2S biogenesis. Biochim Biophys Acta, doi:.
31. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R & Thiemermann C (2009). Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 31, 267-274.
32. Streng T, Axelsson HE, Hedlund P, Andersson DA, Jordt SE, Bevan S, Andersson KE, Hogestatt ED & Zygmunt PM (2008). Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 53, 391-399.
33. Sun YG, Cao YX, Wang WW, Ma SF, Yao T & Zhu YC (2008). Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res 79, 632-641.
34. Szabó G, Veres G, Radovits T, Gero D, Módis K, Miesel-Gröschel C, Horkay F, Karck M & Szabó C (2010). Cardioprotective effects of hydrogen sulfide. Nitric Oxide, doi:.
35. Trevisani M, Patacchini R, Nicoletti P, Gatti R, Gazzieri D, Lissi N, Zagli G, Creminon C, Geppetti P & Harrison S (2005). Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br J Pharmacol 145, 1123-1131.
36. Volpato GP, Searles R, Yu B, Scherrer-Crosbie M, Bloch KD, Ichinose F & Zapol WM (2008). Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology 108, 659-668.
37. Wagner F, Asfar P, Calzia E, Radermacher P & Szabó C (2009). Bench-to-bedside review: Hydrogen sulfide - the third gaseous transmitter: applications for critical care. Crit Care 13, 213.
38. ATP channels. Am J Physiol Heart Circ Physiol 280, H2321-H2328.
39. Wang X, Wang Q, Guo W & Zhu YZ (2011). Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection. Biosci Rep 31, 87-98.
40. Zhang H, Zhi L, Moochhala S, Moore PK & Bhatia M (2007). Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-κB. Am J Physiol Lung Cell Mol Physiol 292, L960-L971.
41. ATP channel opener. EMBO J 20, 6008-6016.